Magnetic resonance susceptibility weighted phase imaging for the assessment of reperfusion intramyocardial hemorrhage

Magnetic Resonance in Medicine

Volumn 71, Issue 3, 2014, Pages 1210-1220

  Goldfarb, James W ^a,b   Hasan, Usama ^a,c   Zhao, Wenguo ^a   Han, Jing ^a  

^a ST FRANCIS HOSPITAL   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c NEW YORK INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

anatomy; cardiovascular; heart; pathology

Indexed keywords

CARDIOLOGY; GADOLINIUM; HEART; HIGH PASS FILTERS; PATHOLOGY;

ANATOMY; CARDIOVASCULAR; CYCLIC VARIATIONS; HEMORRHAGE DETECTION; MYOCARDIAL INFARCTION; NORMAL CONTROLS; NORMAL VARIATIONS; PROSPECTIVE STUDY;

MAGNETIC RESONANCE;

CREATINE KINASE; CREATINE KINASE MB; GADOLINIUM; TROPONIN I;

ACUTE HEART INFARCTION; ANATOMIC LANDMARK; ARTICLE; BLEEDING; CARDIAC IMAGING; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPUTER PROGRAM; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEASIBILITY STUDY; FOLLOW UP; HEART MUSCLE REPERFUSION; HUMAN; INTRAMYOCARDIAL HEMORRHAGE; MYOCARDIAL DISEASE; NUCLEAR MAGNETIC RESONANCE SCANNER; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; SUSCEPTIBILITY WEIGHTED IMAGING; ADULT; AGED; ALGORITHM; COMPUTER ASSISTED DIAGNOSIS; FEMALE; IMAGE ENHANCEMENT; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROCEDURES; REPERFUSION INJURY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; ALGORITHMS; FEMALE; HEMORRHAGE; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL REPERFUSION INJURY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84894478454     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.24747     Document Type: Article

References (70)

1. McNamara RL, Wang Y, Herrin J, Curtis JP, Bradley EH, Magid DJ, Peterson ED, Blaney M, Frederick PD, Krumholz HM,. Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 2006; 47: 2180-2186.
2. Khot UN, Johnson ML, Ramsey C, Khot MB, Todd R, Shaikh SR, Berg WJ,. Emergency department physician activation of the catheterization laboratory and immediate transfer to an immediately available catheterization laboratory reduce door-to-balloon time in ST-elevation myocardial infarction. Circulation 2007; 116: 67-76.
3. Stone GW, Predictors of infarct size after primary coronary angioplasty in acute myocardial infarction from pooled analysis from four contemporary trials. Am J Cardiol 2007; 100: 1370-1375.
4. Berger PB, Ellis SG, Holmes DR, Jr,., Granger CB, Criger DA, Betriu A, Topol EJ, Califf RM., Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: results from the global use of strategies to open occluded arteries in Acute Coronary Syndromes (GUSTO-IIb) trial. Circulation 1999; 100: 14-20.
5. Cannon CP, Gibson CM, Lambrew CT, Shoultz DA, Levy D, French WJ, Gore JM, Weaver WD, Rogers WJ, Tiefenbrunn AJ,. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA 2000; 283: 2941-2947.
6. Yellon DM, Hausenloy DJ,. Myocardial reperfusion injury. N Engl J Med 2007; 357: 1121-1135.
7. Wu KC,. CMR of microvascular obstruction and hemorrhage in myocardial infarction. J Cardiovasc Magn Reson 2012; 14: 68.
8. Garcia-Dorado D, Theroux P, Solares J, Alonso J, Fernandez-Aviles F, Elizaga J, Soriano J, Botas J, Munoz R,. Determinants of hemorrhagic infarcts. Histologic observations from experiments involving coronary occlusion, coronary reperfusion, and reocclusion. Am J Pathol 1990; 137: 301-311.
9. Hillenbrand HB, Kim RJ, Parker MA, Fieno DS, Judd RM,. Early assessment of myocardial salvage by contrast-enhanced magnetic resonance imaging. Circulation 2000; 102: 1678-1683.
10. Abdel-Aty H, Cocker M, Meek C, Tyberg JV, Friedrich MG,. Edema as a very early marker for acute myocardial ischemia: a cardiovascular magnetic resonance study. J Am Coll Cardiol 2009; 53: 1194-1201.
11. Friedrich MG, Abdel-Aty H, Taylor A, Schulz-Menger J, Messroghli D, Dietz R,. The salvaged area at risk in reperfused acute myocardial infarction as visualized by cardiovascular magnetic resonance. J Am Coll Cardiol 2008; 51: 1581-1587.
12. Rochitte CE, Lima JA, Bluemke DA, Reeder SB, McVeigh ER, Furuta T, Becker LC, Melin JA,. Magnitude and time course of microvascular obstruction and tissue injury after acute myocardial infarction. Circulation 1998; 98: 1006-1014.
13. Wu KC, Zerhouni EA, Judd RM, Lugo-Olivieri CH, Barouch LA, Schulman SP, Blumenthal RS, Lima JA,. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 1998; 97: 765-772.
14. Raff GL, O'Neill WW, Gentry RE, Dulli A, Bis KG, Shetty AN, Goldstein JA,. Microvascular obstruction and myocardial function after acute myocardial infarction: assessment by using contrast-enhanced cine MR imaging. Radiology 2006; 240: 529-536.
15. Pedersen SF, Thrysoe SA, Robich MP, Paaske WP, Ringgaard S, Botker HE, Hansen ES, Kim WY,. Assessment of intramyocardial hemorrhage by T1-weighted cardiovascular magnetic resonance in reperfused acute myocardial infarction. J Cardiovasc Magn Reson 2012; 14: 59.
16. Asanuma T, Tanabe K, Ochiai K, et al. Relationship between progressive microvascular damage and intramyocardial hemorrhage in patients with reperfused anterior myocardial infarction: myocardial contrast echocardiographic study. Circulation 1997; 96: 448-453.
17. Basso C, Corbetti F, Silva C, et al. Morphologic validation of reperfused hemorrhagic myocardial infarction by cardiovascular magnetic resonance. Am J Cardiol 2007; 100: 1322-1327.
18. Beek AM, Nijveldt R, van Rossum AC,. Intramyocardial hemorrhage and microvascular obstruction after primary percutaneous coronary intervention. Int J Cardiovasc Imaging 2010; 26: 49-55.
19. Cannan C, Eitel I, Hare J, Kumar A, Friedrich M,. Hemorrhage in the myocardium following infarction. JACC Cardiovasc Imaging 2010; 3: 665-668.
20. Eitel I, Kubusch K, Strohm O, Desch S, Mikami Y, de Waha S, Gutberlet M, Schuler G, Friedrich MG, Thiele H,. Prognostic value and determinants of a hypointense infarct core in T2-weighted cardiac magnetic resonance in acute reperfused ST-elevation-myocardial infarction. Circ Cardiovasc Imaging 2011; 4: 354-362.
21. Foltz WD, Yang Y, Graham JJ, Detsky JS, Wright GA, Dick AJ,. MRI relaxation fluctuations in acute reperfused hemorrhagic infarction. Magn Reson Med 2006; 56: 1311-1319.
22. Francone M, Carbone I, Agati L, Bucciarelli Ducci C, Mangia M, Iacucci I, Catalano C, Passariello R,. Utility of T2-weighted short-tau inversion recovery (STIR) sequences in cardiac MRI: an overview of clinical applications in ischaemic and non-ischaemic heart disease. Radiol Med 2011; 116: 32-46.
23. Ganame J, Messalli G, Dymarkowski S, Rademakers FE, Desmet W, Van de Werf F, Bogaert J,. Impact of myocardial haemorrhage on left ventricular function and remodelling in patients with reperfused acute myocardial infarction. Eur Heart J 2009; 30: 1440-1449.
24. Jackowski C, Christe A, Sonnenschein M, Aghayev E, Thali MJ,. Postmortem unenhanced magnetic resonance imaging of myocardial infarction in correlation to histological infarction age characterization. Eur Heart J 2006; 27: 2459-2467.
25. Lotan CS, Miller SK, Bouchard A, Cranney GB, Reeves RC, Bishop SP, Elgavish GA, Pohost GM,. Detection of intramyocardial hemorrhage using high-field proton (1H) nuclear magnetic resonance imaging. Cathet Cardiovasc Diagn 1990; 20: 205-211.
26. Mather AN, Fairbairn TA, Ball SG, Greenwood JP, Plein S,. Reperfusion haemorrhage as determined by cardiovascular MRI is a predictor of adverse left ventricular remodelling and markers of late arrhythmic risk. Heart 2011; 97: 453-459.
27. Mikami Y, Sakuma H, Nagata M, Ishida M, Kurita T, Komuro I, Ito M,. Relation between signal intensity on T2-weighted MR images and presence of microvascular obstruction in patients with acute myocardial infarction. AJR Am J Roentgenol 2009; 193: W321-W326.
28. O'Regan DP, Ahmed R, Karunanithy N, Neuwirth C, Tan Y, Durighel G, Hajnal JV, Nadra I, Corbett SJ, Cook SA,. Reperfusion hemorrhage following acute myocardial infarction: assessment with T2* mapping and effect on measuring the area at risk. Radiology 2009; 250: 916-922.
29. Porto I, Hamilton-Craig C, De Maria GL, et al. Quantitative Blush Evaluator accurately quantifies microvascular dysfunction in patients with ST-elevation myocardial infarction: Comparison with cardiovascular magnetic resonance. Am Heart J 2011; 162: 372-381 e372.
30. Ochiai K, Shimada T, Murakami Y, Ishibashi Y, Sano K, Kitamura J, Inoue S, Murakami R, Kawamitsu H, Sugimura K,. Hemorrhagic myocardial infarction after coronary reperfusion detected in vivo by magnetic resonance imaging in humans: prevalence and clinical implications. J Cardiovasc Magn Reson 1999; 1: 247-256.
31. O'Regan DP, Ariff B, Neuwirth C, Tan Y, Durighel G, Cook SA,. Assessment of severe reperfusion injury with T2* cardiac MRI in patients with acute myocardial infarction. Heart 2010; 96: 1885-1891.
32. Dumoulin CL,. Phase contrast MR angiography techniques. Magn Reson Imaging Clin N Am 1995; 3: 399-411.
33. Rauscher A, Sedlacik J, Barth M, Mentzel HJ, Reichenbach JR,. Magnetic susceptibility-weighted MR phase imaging of the human brain. AJNR Am J Neuroradiol 2005; 26: 736-742.
34. Haacke EM, Xu Y, Cheng YC, Reichenbach JR,. Susceptibility weighted imaging (SWI). Magn Reson Med 2004; 52: 612-618.
35. Marks B, Mitchell DG, Simelaro JP,. Breath-holding in healthy and pulmonary-compromised populations: effects of hyperventilation and oxygen inspiration. J Magn Reson Imaging 1997; 7: 595-597.
36. Kim RJ, Shah DJ, Judd RM,. How we perform delayed enhancement imaging. J Cardiovasc Magn Reson 2003; 5: 505-514.
37. Amado LC, Gerber BL, Gupta SN, Rettmann DW, Szarf G, Schock R, Nasir K, Kraitchman DL, Lima JA,. Accurate and objective infarct sizing by contrast-enhanced magnetic resonance imaging in a canine myocardial infarction model. J Am Coll Cardiol 2004; 44: 2383-2389.
38. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS,. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002; 105: 539-542.
39. Oppenheim AV, Schafer RW,. Discrete-time signal processing. Englewood Cliffs, NJ: Prentice-Hall; 1989.
40. Kumar A, Green JD, Sykes JM, Ephrat P, Carson JJ, Mitchell AJ, Wisenberg G, Friedrich MG,. Detection and quantification of myocardial reperfusion hemorrhage using T2*-weighted CMR. JACC Cardiovasc Imaging 2011; 4: 1274-1283.
41. Anderson LJ, Holden S, Davis B, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001; 22: 2171-2179.
42. Anderson LJ, Wonke B, Prescott E, Holden S, Walker JM, Pennell DJ,. Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia. Lancet 2002; 360: 516-520.
43. Carpenter JP, He T, Kirk P, et al. On T2* magnetic resonance and cardiac iron. Circulation 2011; 123: 1519-1528.
44. Kirk P, He T, Anderson LJ, et al. International reproducibility of single breathhold T2* MR for cardiac and liver iron assessment among five thalassemia centers. J Magn Reson Imaging 2010; 32: 315-319.
45. Kirk P, Smith GC, Roughton M, He T, Pennell DJ,. Myocardial T2* is not affected by ageing, myocardial fibrosis, or impaired left ventricular function. J Magn Reson Imaging 2010; 32: 1095-1098.
46. Meloni A, Pepe A, Positano V, et al. Influence of myocardial fibrosis and blood oxygenation on heart T2* values in thalassemia patients. J Magn Reson Imaging 2009; 29: 832-837.
47. Smith GC, Carpenter JP, He T, Alam MH, Firmin DN, Pennell DJ,. Value of black blood T2* cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2011; 13: 21.
48. Positano V, Pepe A, Santarelli MF, et al. Multislice multiecho T2* cardiac magnetic resonance for the detection of heterogeneous myocardial iron distribution in thalassaemia patients. NMR Biomed 2009; 22: 707-715.
49. Positano V, Pepe A, Santarelli MF, et al. Standardized T2* map of normal human heart in vivo to correct T2* segmental artefacts. NMR Biomed 2007; 20: 578-590.
50. Friedrich MG, Kim HW, Kim RJ,. T2-weighted imaging to assess post-infarct myocardium at risk. JACC Cardiovasc Imaging 2011; 4: 1014-1021.
51. Croisille P, Kim HW, Kim RJ,. Controversies in cardiovascular MR imaging: T2-weighted imaging should not be used to delineate the area at risk in ischemic myocardial injury. Radiology 2012; 265: 12-22.
52. Srichai MB, Lim RP, Lath N, Babb J, Axel L, Kim D,. Diagnostic performance of dark-blood T2-weighted CMR for evaluation of acute myocardial injury. Invest Radiol 2013; 48: 24-31.
53. He T, Gatehouse PD, Anderson LJ, Tanner M, Keegan J, Pennell DJ, Firmin DN,. Development of a novel optimized breathhold technique for myocardial T2 measurement in thalassemia. J Magn Reson Imaging 2006; 24: 580-585.
54. Keegan J, Gatehouse PD, Prasad SK, Firmin DN,. Improved turbo spin-echo imaging of the heart with motion-tracking. J Magn Reson Imaging 2006; 24: 563-570.
55. Goldfarb JW, McLaughlin J, Gray CA, Han J,. Cyclic CINE-balanced steady-state free precession image intensity variations: implications for the detection of myocardial edema. J Magn Reson Imaging 2011; 33: 573-581.
56. Goldfarb JW, Arnold S, Roth M, Han J,. T1-weighted magnetic resonance imaging shows fatty deposition after myocardial infarction. Magn Reson Med 2007; 57: 828-834.
57. Weber OM, Speier P, Scheffler K, Bieri O,. Assessment of magnetization transfer effects in myocardial tissue using balanced steady-state free precession (bSSFP) cine MRI. Magn Reson Med 2009; 62: 699-705.
58. Goldfarb JW, Arnold S, Han J,. Recent myocardial infarction: assessment with unenhanced T1-weighted MR imaging. Radiology 2007; 245: 245-250.
59. Tong KA, Ashwal S, Obenaus A, Nickerson JP, Kido D, Haacke EM,. Susceptibility-weighted MR imaging: a review of clinical applications in children. AJNR Am J Neuroradiol 2008; 29: 9-17.
60. Liu T, Surapaneni K, Lou M, Cheng L, Spincemaille P, Wang Y,. Cerebral microbleeds: burden assessment by using quantitative susceptibility mapping. Radiology 2012; 262: 269-278.
61. Moseley ME, Mintorovitch J, Cohen Y, Asgari HS, Derugin N, Norman D, Kucharczyk J,. Early detection of ischemic injury: comparison of spectroscopy, diffusion-, T2-, and magnetic susceptibility-weighted MRI in cats. Acta Neurochir Suppl (Wien) 1990; 51: 207-209.
62. Haacke EM,. Susceptibility weighted imaging (SWI). Z Med Phys 2006; 16: 237.
63. Basso C, Thiene G,. The pathophysiology of myocardial reperfusion: a pathologist's perspective. Heart 2006; 92: 1559-1562.
64. Fishbein MC, Y-Rit J, Lando, U, Kanmatsuse, K, Mercier, JC, Ganz, W,. The relationship of vascular injury and myocardial hemorrhage to necrosis after reperfusion. Circulation 1980; 62: 1274-1279.
65. Reffelmann T, Kloner RA,. Microvascular reperfusion injury: rapid expansion of anatomic no reflow during reperfusion in the rabbit. Am J Physiol Heart Circ Physiol 2002; 283: H1099-H1107.
66. Beek AM, Kuhl HP, Bondarenko O, Twisk JW, Hofman MB, van Dockum WG, Visser CA, van Rossum AC,. Delayed contrast-enhanced magnetic resonance imaging for the prediction of regional functional improvement after acute myocardial infarction. J Am Coll Cardiol 2003; 42: 895-901.
67. Bekkers SC, Backes WH, Kim RJ, Snoep G, Gorgels AP, Passos VL, Waltenberger J, Crijns HJ, Schalla S,. Detection and characteristics of microvascular obstruction in reperfused acute myocardial infarction using an optimized protocol for contrast-enhanced cardiovascular magnetic resonance imaging. Eur Radiol 2009; 19: 2904-2912.
68. Hombach V, Grebe O, Merkle N, Waldenmaier S, Hoher M, Kochs M, Wohrle J, Kestler HA,. Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging. Eur Heart J 2005; 26: 549-557.
69. Lund GK, Stork A, Saeed M, Bansmann MP, Gerken JH, Muller V, Mester J, Higgins CB, Adam G, Meinertz T,. Acute myocardial infarction: evaluation with first-pass enhancement and delayed enhancement MR imaging compared with 201Tl SPECT imaging. Radiology 2004; 232: 49-57.
70. Mather AN, Lockie T, Nagel E, Marber M, Perera D, Redwood S, Radjenovic A, Saha A, Greenwood JP, Plein S,. Appearance of microvascular obstruction on high resolution first-pass perfusion, early and late gadolinium enhancement CMR in patients with acute myocardial infarction. J Cardiovasc Magn Reson 2009; 11: 33